[Serum level of TNF-alpha receptor type II better correlates with severity of Crohn's disease than other cytokines and conventional clinical activity indicators].

Serum chemerin and vaspin in non-alcoholic fatty liver disease. Scand J Gastroenterol (2010) 1.69

Kidneys in chronic liver diseases. World J Gastroenterol (2012) 1.10

Nodular regenerative hyperplasia: evolving concepts on underdiagnosed cause of portal hypertension. World J Gastroenterol (2011) 1.00

Liver injury induced by high-dose methylprednisolone therapy: a case report and brief review of the literature. Hepat Mon (2011) 0.97

Liver visfatin expression in morbidly obese patients with nonalcoholic fatty liver disease undergoing bariatric surgery. Pol J Pathol (2010) 0.87

Validation of the BARD scoring system in Polish patients with nonalcoholic fatty liver disease (NAFLD). BMC Gastroenterol (2010) 0.85

Composite neuroendocrine and adenomatous carcinoma of the papilla of Vater. World J Gastroenterol (2009) 0.85

Severe dilated cardiomyopathy as a consequence of Ecstasy intake. Cardiovasc Pathol (2007) 0.84

The dynamics of the oxidant-antioxidant balance in the early phase of human acute biliary pancreatitis. Pancreatology (2004) 0.82

Laboratory-based scoring system for prediction of hepatic inflammatory activity in patients with autoimmune hepatitis. Liver Int (2013) 0.81

Suitability of imaging methods (X-ray, CT, MRI) in the diagnostics of Ewing's sarcoma in children - analysis of own material. Pol J Radiol (2010) 0.79

Haemobilia causing acute pancreatitis after percutaneous liver biopsy. J Hepatol (2004) 0.79

Hepatic angiogenesis and fibrosis are common features in morbidly obese patients. Hepatol Int (2011) 0.79

[Significance of serum concentrations of pro- and anti-inflammatory cytokines in identification of patients with Crohn's disease]. Pol Merkur Lekarski (2010) 0.78

Serum vaspin may be a good indicator of fibrosis in chronic hepatitis C and is not altered by antiviral therapy. Pol J Pathol (2012) 0.77

In patients with liver cirrhosis, proinflammatory interleukins correlate with health-related quality of life irrespective of minimal hepatic encephalopathy. Eur J Gastroenterol Hepatol (2013) 0.77

Omentin serum concentration and hepatic expression in chronic hepatitis C patients - together or apart? Pol J Pathol (2015) 0.77

Comment on "Hepatitis C virus-specific Th17 cells are suppressed by virus-induced TGF-beta". J Immunol (2009) 0.77

Treatment of pruritus with Prometheus dialysis and absorption system in a patient with benign recurrent intrahepatic cholestasis. Hepatol Res (2013) 0.76

Quality of life in patients with Irritable Bowel Syndrome (IBS), assessed using the IBS-Quality of Life (IBS-QOL) measure after 4 and 8 weeks of treatment with mebeverine hydrochloride or pinaverium bromide: results of an international prospective observational cohort study in Poland, Egypt, Mexico and China. Clin Drug Investig (2014) 0.76

Critical flicker frequency fails to disclose brain dysfunction in patients with primary biliary cirrhosis. Dig Liver Dis (2010) 0.76

Age and immunoglobulin G4-associated autoimmune hepatitis. Liver Int (2009) 0.75

A composite model including visfatin, tissue polypeptide-specific antigen, hyaluronic acid, and hematological variables for the diagnosis of moderate-to-severe fibrosis in nonalcoholic fatty liver disease: a preliminary study. Pol Arch Med Wewn (2014) 0.75

Left-hemihepatectomy as a method of treatment of locally limited Caroli disease. Pol Przegl Chir (2013) 0.75

[Evaluation of probability of bile duct stone presence by using of non-invasive procedures]. Pol Arch Med Wewn (2003) 0.75

[Inflammatory bowel diseases in pregnancy]. Ginekol Pol (2009) 0.75

Vaspin mRNA levels in the liver of morbidly obese women with nonalcoholic fatty liver disease. Pol J Pathol (2017) 0.75

Autoimmune LKM1 hepatitis presenting in the form of recurrent acute episodes. Am J Gastroenterol (2002) 0.75

[Assessment of prevalence of intrapulmonary arterio-venous shunt in cirrhotic patients qualified to liver transplantation]. Wiad Lek (2009) 0.75

Hepatic arterial dot signs in isolated small duct primary sclerosing cholangitis. J Gastroenterol Hepatol (2004) 0.75

[Autoimmune hepatitis in the sight of contemporary immunology]. Pol Arch Med Wewn (2002) 0.75

Hepatic chemerin mRNA in morbidly obese patients with nonalcoholic fatty liver disease. Pol J Pathol (2017) 0.75

A rare cause of chylous ascites. Liver Int (2011) 0.75

[Endoscopic assessment of large bowel and safety of bowel preparation and sedoanalgesia in patients with advanced liver cirrhosis]. Przegl Lek (2011) 0.75

[Alcoholic liver disease]. Wiad Lek (2003) 0.75

Cytophagic hemorrhagic panniculitis and severe steatohepatitis: challenging combination. J Gastroenterol Hepatol (2005) 0.75

[85-years-old patient with paraneoplastic polyneuropathy]. Wiad Lek (2007) 0.75

An unusual cause of hepatic encephalopathy. Pol Arch Med Wewn (2015) 0.75

Pernicious anemia during peginterferon-alpha2b plus ribavirin therapy for chronic hepatitis C. Eur J Gastroenterol Hepatol (2009) 0.75

Comparison of patency and cost-effectiveness of self-expandable metal and plastic stents used for malignant biliary strictures: a Polish single-center study. Eur J Gastroenterol Hepatol (2016) 0.75

Moyamoya-like vascular pattern of the hepatic portal in primary sclerosing cholangitis associated with portal vein occlusion. Ultraschall Med (2007) 0.75